Navigation Links
NCPA Endorses U.S. Senator Mark Pryor for Re-Election
Date:10/8/2008

ALEXANDRIA, Va., Oct. 8 /PRNewswire-USNewswire/ -- The National Community Pharmacists Association (NCPA) is endorsing Sen. Mark Pryor (D-AR), a one-term incumbent representing Arkansas, for re-election to the U.S. Senate. Bruce Roberts, RPh, executive vice president and CEO of NCPA, issued the following statement:

"Senator Mark Pryor is a powerful advocate for Arkansas and America's community pharmacies and the patients they serve. That is why the National Community Pharmacists Association strongly endorses him for re-election to the U.S. Senate."

"Sen. Pryor is a proven leader in Arkansas, who recognizes the importance of bolstering healthcare resources for his constituents. We encourage the voters in his state to make the wise choice and return him to the Senate again with their votes on November 4th."

The National Community Pharmacists Association, founded in 1898, represents the nation's community pharmacists, including the owners of more than 23,000 pharmacies. The nation's independent pharmacies, independent pharmacy franchises, and independent chains dispense nearly half of the nation's retail prescription medicines. To learn more go to http://www.ncpanet.org.


'/>"/>
SOURCE National Community Pharmacists Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. NCPA Endorses U.S. Senator Tim Johnson for Re-Election
2. NCPA Endorses U.S. Senator Max Baucus for Re-Election
3. NCPA Endorses U.S. Senator Pat Roberts for Re-Election
4. NCPA Endorses U.S. Senator Gordon Smith for Re-Election
5. National Business Coalition on Health Endorses New CMS Never Events Policy
6. National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting
7. Minnesota Nurses Association Endorses Ashwin Madia for Congress
8. Minnesota Nurses Association Endorses Steve Sarvi for Congress
9. Minnesota Nurses Association Endorses Elwyn Tinklenberg for Congress
10. American Right to Life Endorses U.S. Senator Roger Wickers Life at Conception Act
11. National Staff Nurses Union Endorses Obama for President; UAN Leaders Cite Obamas Commitment to Working Families, Health Care Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... Raton (PRWEB) , ... September 19, 2017 , ... ... the El Naturalista brand, developed by ACPG Laboratories, is coming soon to RonnieColemanNutrition.com. ... in Spain, and El Naturalista is a trusted, well-respected brand reliant on the ...
(Date:9/19/2017)... ... ... For decades doctors, nurses, and other healthcare providers have been trained to ... calculating their cardiovascular disease (CVD) risk in the next 10 years. , Imagine ... an estimated 10-year risk prediction! , Imagine if the weatherman says there is a ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... with the Davidson Fellows Scholarship on September 27 at a reception in Washington ... Technology, Engineering, Mathematics, Literature and Music. , “I am honored to be a ...
(Date:9/19/2017)... ... September 19, 2017 , ... Emergency nursing expertise, skill ... Emergency Nurse (CEN®) certification according to a large-scale study announced today by ... conducted by the Human Resources Research Organization (HumRRO) in late 2016 and early ...
(Date:9/18/2017)... Bangkok, Thailand (PRWEB) , ... September 19, 2017 ... ... in Asia Pacific’s protein ingredient market , expected to grow at the ... Frost & Sullivan sharing the ‘Global Food Protein Trends & Growth Opportunities in ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... Sept. 7, 2017   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade cell and tissue hypothermic storage ... Mike Rice , President and CEO, will be presenting ... Rodman & Renshaw 19 th Annual Global Investment ... (12:25 p.m. Pacific time). The conference is being held at ...
(Date:9/6/2017)... INDIANAPOLIS , Sept. 6, 2017 Eli ... today it will present new data for galcanezumab and ... Congress of the International Headache Society (IHC) taking place ... Lilly will highlight new, long-term data from ... two doses of galcanezumab (120 mg and 240 mg) ...
(Date:9/5/2017)... JERUSALEM , Sept. 5, 2017 Oramed Pharmaceuticals ... www.oramed.com ), a clinical-stage pharmaceutical company focused on the ... it has successfully concluded its meeting with the U.S. ... novel oral insulin formulation. ... that the regulatory pathway for submission of ORMD-0801, would ...
Breaking Medicine Technology: